Novo Holdings Portfolio Holdings

Novo Holdings

  • $1.11 Billion
  • Q1 2025

Novo Holdings has filed its 13F form on May 15, 2025 for Q1 2025 where it was disclosed a total value porftolio of $1.11 Billion distributed in 31 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Vanguard Total Stock Market Et with a value of $285M, Edgewise Therapeutics, Inc. with a value of $118M, Asml Holding Nv with a value of $110M, Salesforce, Inc. with a value of $73.2M, and Mirum Pharmaceuticals, Inc. with a value of $67.6M.

Examining the 13F form we can see an decrease of $119M in the current position value, from $1.23B to 1.11B.

Novo Holdings is based out at Hellerup, G7

Below you can find more details about Novo Holdings portfolio as well as his latest detailed transactions.

Portfolio value $1.11 Billion
Healthcare: $592 Million
ETFs: $285 Million
Technology: $185 Million
Consumer Cyclical: $49.2 Million

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$0
$285 Million 25.67% of portfolio
1,038,550
Q2 2024 New
$936M
$118 Million 10.59% of portfolio
5,350,000
Q1 2025 Added 7.0%
$297B
$110 Million 9.88% of portfolio
165,836
Q4 2024 Added 24.37%
$288B
$73.2 Million 6.58% of portfolio
272,801
Q1 2025 Reduced 7.18%
$1.65B
$67.6 Million 6.08% of portfolio
1,500,000
Q3 2023 Reduced 10.94%
$9.2B
$55.3 Million 4.97% of portfolio
724,666
Q3 2024 Reduced 9.42%
$814M
$51.1 Million 4.6% of portfolio
9,665,128
Q1 2025 Reduced 4.44%
$331B
$49.2 Million 4.43% of portfolio
372,327
Q1 2025 Reduced 17.69%
$1.69B
$42.8 Million 3.85% of portfolio
1,275,000
Q1 2025 Added 32.78%
$11.1B
$34.6 Million 3.12% of portfolio
490,000
Q2 2024 Added 8.89%
$2.17B
$34.6 Million 3.11% of portfolio
915,000
Q1 2025 Added 22.0%
$1.9B
$33.2 Million 2.99% of portfolio
789,129
Q1 2025 Added 5.22%
$522M
$30.3 Million 2.73% of portfolio
2,250,300
Q1 2025 Added 0.01%
$564M
$27.1 Million 2.44% of portfolio
1,725,000
Q2 2024 Added 47.68%
$1.8B
$22.4 Million 2.02% of portfolio
2,750,000
Q1 2025 Added 10.0%
$978M
$21.8 Million 1.96% of portfolio
1,200,000
Q1 2025 Added 20.0%
$262M
$13.7 Million 1.23% of portfolio
3,000,000
Q1 2025 Added 25.0%
$488M
$7.34 Million 0.66% of portfolio
1,100,000
Q2 2024 Added 4.76%
$123M
$6.3 Million 0.57% of portfolio
1,950,000
Q1 2025 Added 30.0%
$30.3M
$3.66 Million 0.33% of portfolio
3,354,449
Q3 2024 Reduced 24.27%
$576M
$2.51 Million 0.23% of portfolio
1,126,915
Q2 2022 New
$2.34B
$1.82 Million 0.16% of portfolio
441,558
Q4 2021 New
Arrivent Biopharma Inc
-
$0 0.0% of portfolio
-
Q1 2025 Added 23.12%
Brookfield Corp
-
$0 0.0% of portfolio
-
Q1 2025 Reduced 16.72%
Ceribell Inc
-
$0 0.0% of portfolio
-
Q1 2025 Added 167.63%
Galecto Inc
-
$0 0.0% of portfolio
-
Q3 2024 New
Kyverna Therapeutics Inc
-
$0 0.0% of portfolio
-
Q3 2024 Added 5.71%
Lanzatech Global Inc
-
$0 0.0% of portfolio
-
Q1 2023 New
Lexeo Therapeutics Inc
-
$0 0.0% of portfolio
-
Q3 2024 Reduced 22.61%
Zenas Biopharma Inc
-
$0 0.0% of portfolio
-
Q1 2025 Added 38.44%

Summary

  • Portfolio
  • No. of Stocks 31
  • Current Value $1.11 Billion
  • Prior Value $1.23 Billion
  • Filing
  • Period Q1 2025
  • Filing Date May 15, 2025
  • Form Type 13F-HR
  • Activity in Q1 2025
  • New Purchases 0 stocks
  • Additional Purchases 13 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 4 stocks
Track This Portfolio

Track Novo Holdings Portfolio

Follow Novo Holdings and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Novo Holdings, based on Form 13F filings with the SEC.

News

Stay updated on Novo Holdings with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email